Read OSN’s Aug. 25 publication exclusives online

The August 25, 2018, edition of Ocular Surgery News featured a cover story focused on more personalized treatments for neovascular AMD, including treat-and-extend options. Here are some of the issue’s publication exclusives:

Cover story

Treat-and-extend increasingly gains favor for individualized, proactive management of neovascular AMD

Over time, based on the results of clinical trials and their extensions, the revealing outcomes of real-life studies, and the long experience and consensus statements of many experts, the attitudes and habits of retina specialists have changed. Read more.

Lindstrom’s Perspective

Better monitoring, delivery systems needed for anti-VEGFs

Intravitreal anti-VEGF injections for wet or exudative age-related macular degeneration are a truly disruptive, unexpected and amazing advance in our treatment of AMD. In the FDA studies, those patients who received monthly examinations and injections achieved amazing outcomes, especially when caught in the earliest stages of the disease. Read more.

Back to Basics

Surgical repair of corneal laceration and anterior lens capsule rupture

A patient presents to our resident ophthalmology clinic with a 1-day history of a nail piercing his eye while doing construction work. Fortunately, the trauma is not high speed and the damage is limited to the anterior segment of the eye. Read more.

The Dry Eye

Follow the money: A possible solution from D.C.?

Do you read financial news? You know, the Wall Street Journal, Investor’s Business Daily or at least the business section of your local rag? You really should. There is all kinds of stuff in there that is important and affects your everyday practice experience no matter what kind of practice you may have. Read more.

Point/Counter

When treating patients with age-related macular degeneration, do you perform bilateral same-day intravitreal injections?

Two surgeons give differing perspectives regarding same-day injections. Read more.